Dapagliflozin in Heart Failure, Type 2 Diabetes, and Neuropathy: A Meta-Analysis of DAPA-HF and DELIVER

被引：0

作者：

Butt, Jawad H. ^{[1
,2
,3
]}

Shen, Li ^{[1
]}

Inzucchi, Silvio E. ^{[4
]}

Docherty, Kieran F. ^{[1
]}

Jhund, Pardeep S. ^{[1
]}

Martinez, Felipe A. ^{[5
]}

Sabatine, Marc S. ^{[6
]}

Vaduganathan, Muthiah ^{[6
]}

Solomon, Scott D. ^{[6
]}

McMurray, John J. V. ^{[1
]}

机构：

[1] Univ Glasgow, Glasgow, Scotland

[2] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark

[3] Zealand Univ Hosp, Roskilde, Denmark

[4] Yale Sch Med, New Haven, CT USA

[5] Univ Cordoba, Cordoba, Argentina

[6] Brigham & Womens Hosp, Boston, MA USA

来源：

JACC-HEART FAILURE | 2024年 / 12卷 / 11期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1016/j.jchf.2024.07.017

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1946 / 1948

页数：3

共 50 条

[41] The Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF): Results in Nondiabetic Patients
McMurray, John J.
DeMets, David L.
Inzucchi, Silvio E.
Kober, Lars
Kosiborod, Mikhail N.
Langkilde, Anna Maria
Martinez, Felipe
Bengtsson, Olof
Ponikowski, Piotr
Sabatine, Marc S.
Sjostrand, Mikaela
Solomon, Scott
CIRCULATION, 2019, 140 (25) : E965 - E965
[42] Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)
Serenelli, Matteo
Boehm, Michael
Inzucchi, Silvio E.
Kober, Lars
Kosiborod, Mikhail N.
Martinez, Felipe A.
Ponikowski, Piotr
Sabatine, Marc S.
Solomon, Scott D.
DeMets, David L.
Bengtsson, Olof
Sjostrand, Mikaela
Langkilde, Anna Maria
Anand, Inder S.
Chiang, Chern-En
Chopra, Vijay K.
de Boer, Rudolf A.
Diez, Mirta
Dukat, Andrej
Ge, Junbo
Howlett, Jonathan G.
Katova, Tzvetana
Kitakaze, Masafumi
Ljungman, Charlotta E. A.
Verma, Subodh
Docherty, Kieran F.
Jhund, Pardeep S.
McMurray, John J., V
EUROPEAN HEART JOURNAL, 2020, 41 (36) : 3402 - 3418
[43] Association of Dapagliflozin Use With Clinical Outcomes and the Introduction of Uric Acid-Lowering Therapy and Colchicine in Patients With Heart Failure With and Without Gout A Patient-Level Pooled Meta-analysis of DAPA-HF and DELIVER
Butt, Jawad H.
Docherty, Kieran F.
Claggett, Brian L.
Desai, Akshay S.
Petersson, Magnus
Langkilde, Anna Maria
de Boer, Rudolf A.
Hernandez, Adrian F.
Inzucchi, Silvio E.
Kosiborod, Mikhail N.
Kober, Lars
Lam, Carolyn S. P.
Martinez, Felipe A.
Ponikowski, Piotr
Sabatine, Marc S.
Shah, Sanjiv J.
Vaduganathan, Muthiah
Jhund, Pardeep S.
Solomon, Scott D.
McMurray, John J. V.
JAMA CARDIOLOGY, 2023, 8 (04) : 386 - 393
[44] Age and Heart Failure Trials - Lessons from DAPA-HF
Rich, Michael W.
Goyal, Parag
Forman, Daniel E.
JOURNAL OF CARDIAC FAILURE, 2020, 26 (03) : 191 - 192
[45] Differences in Clinical Characteristics, Outcomes, and Treatment Response to Dapagliflozin Across the Range of Ejection Fraction in Black and White Patients With Heart Failure: A Pooled Analysis of Dapa-hf and Deliver
Butt, Jawad H.
Jhund, Pardeep S.
Vaduganathan, Muthiah
De Boer, Rudolf A.
Lam, Carolyn S.
Martinez, Felipe
Inzucchi, Silvio E.
Hernandez, Adrian F.
Desai, Akshay S.
Shah, Sanjiv J.
Kosiborod, Mikhail N.
Langkilde, Anna Maria
Petersson, Magnus
Lindholm, Daniel
Bengtsson, Olof
Wilderang, Ulrica
Vardeny, Orly
Fang, James C.
Verma, Subodh
OMeara, Eileen
Cabrera, Walter
Solomon, Scott
McMurray, John J.
CIRCULATION, 2022, 146 (25) : E598 - E598
[46] Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER
Wang, Xiaowen
Vaduganathan, Muthiah
Claggett, Brian L.
Hegde, Sheila M.
Pabon, Maria
Kulac, Ian J.
Vardeny, Orly
O'Meara, Eileen
Zieroth, Shelley
Katova, Tzvetana
McGrath, Martina M.
Pouleur, Anne-Catherine
Jhund, Pardeep S.
Desai, Akshay S.
Inzucchi, Silvio E.
Kosiborod, Mikhail N.
de Boer, Rudolf A.
Kober, Lars
Sabatine, Marc S.
Martinez, Felipe A.
Ponikowski, Piotr
Shah, Sanjiv J.
Hernandez, Adrian F.
Langkilde, Anna Maria
McMurray, John J., V
Solomon, Scott D.
Lam, Carolyn S. P.
CIRCULATION, 2023, 147 (08) : 624 - 634
[47] Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction A Participant-Level Pooled Analysis of DAPA-HF and DELIVER
Desai, Akshay S.
Jhund, Pardeep S.
Claggett, Brian L.
Vaduganathan, Muthiah
Miao, Zi Michael
Kondo, Toru
Barkoudah, Ebrahim
Brahimi, Abdel
Connolly, Eugene
Finn, Peter
Lang, Ninian N.
Mc Causland, Finnian R.
McGrath, Martina
Petrie, Mark C.
McMurray, John J., V
Solomon, Scott D.
JAMA CARDIOLOGY, 2022, 7 (12) : 1227 - 1234
[48] Effect of dapagliflozin on outcomes according to aetiology in patients with heart failure and reduced ejection fraction in the DAPA-HF trial
Butt, J. H.
Kober, L.
Docherty, K. F.
Inzucchi, S. E.
Kosiborod, M. N.
Langkilde, A. M.
Martinez, F. A.
Bengtsson, O.
Ponikowski, P.
Demets, D. L.
Sjostrand, M.
Sabatine, M. S.
Solomon, S. D.
Jhund, P. S.
Mcmurray, J. John
EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 10 - 10
[49] Effects of dapagliflozin according to QRS duration across the spectrum of left ventricular ejection fraction: An analysis of DAPA-HF and DELIVER
Abdin, Amr
Kondo, Toru
Boehm, Michael
Jhund, Pardeep S.
Claggett, Brian L.
Vaduganathan, Muthiah
Hernandez, Adrian F.
Lam, Carolyn S. P.
Inzucchi, Silvio E.
Martinez, Felipe A.
de Boer, Rudolf A.
Desai, Akshay S.
Kober, Lars
Sabatine, Marc S.
Petersson, Magnus
Bachus, Erasmus
Solomon, Scott D.
McMurray, John J. V.
EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (09) : 1952 - 1963
[50] Effect of Treatment According to Age in the Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF)
Martinez, Felipe
DeMets, David L.
Inzucchi, Silvio E.
Kober, Lars
Kosiborod, Mikhail N.
Langkilde, Anna Maria
Bengtsson, Olof
Ponikowski, Piotr
Sabatine, Marc S.
Sjostrand, Mikaela
Solomon, Scott
McMurray, John J.
CIRCULATION, 2019, 140 (25) : E994 - E994

← 1 2 3 4 5 →